Cancer
Precision Medicine
Hoag named Dr. Michael Demeure program director of precision medicine, a new program focused on tailoring cancer treatment options for each patient. He’ll lead strategy and development of the program, identify partners, develop a Hoag molecular tumor board, and assess software development. Hoag Family Cancer Institute now utilizes genomic profiling, a system “previously only accessible … Read More